Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 019170344 approvals76 trials

SHINPOONG PHARMACEUTICAL CO.,LTD

Official website

Founded in 1986 and listed on the KOSPI in 1990, Shinpoong Pharmaceutical manufactures antibiotics, thrombolytics, psychotropics, and anthelmintics.

As of 2026-10-10, SHINPOONG PHARMACEUTICAL CO.,LTD has 4 Korean MFDS device approvals, 340 Korean MFDS drug approvals, 8 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • AntibioticsAntibiotic
  • ThrombolyticsThrombolytic agent
  • Psychotropic drugsPsychotropic drug
  • AnthelminticsAnthelmintic

Regulatory approvals

data.go.kr

340 Korean MFDS drug approvals · 1982–2026 / 4 Korean MFDS device approvals · 2011–2014

  • MFDS drugDenobone Prefilled Syringe2026-09-03
    Drug · Prescription · Approval202602634
  • MFDS drugShinpoong Fosfomycin Sodium 4g for Injection2026-04-06
    Drug · Prescription · Approval202600958
  • MFDS drugStafeno Capsule2025-04-30
    Drug · Prescription · Approval202501046
  • MFDS drugMyvical tab.2025-03-17
    Drug · OTC · Notification202500577
  • MFDS drugAvocial Tablet 0.5/5mg(Dutasteride,Tadalafil)2025-01-23
    Drug · Prescription · Approval202500184
  • MFDS drugHighginkgo Tab. 240mg2024-12-12
    Drug · OTC · Notification202402950
  • MFDS drugShinpoong Fosfomycin Sodium 3% for Otic2024-10-18
    Drug · Prescription · Approval202402463
  • MFDS drugShinpoong Fosfomycin Sodium 2g for Injection2024-09-09
    Drug · Prescription · Approval202402186
  • MFDS drugShinpoong Fosfomycin Sodium 1g for Injection2024-09-09
    Drug · Prescription · Approval202402187
  • MFDS drugShinpoong Fosfomycin Sodium 0.5g for Injection2024-09-09
    Drug · Prescription · Approval202402188
  • MFDS drugHyalflex Injection2024-07-12
    Drug · Prescription · Approval202401722
  • MFDS drugShinpoong azithromycin tablet 500mg2024-06-28
    Drug · Prescription · Approval202401582
Show 68 more
  • MFDS drugCeracin Capsule 400mg2024-05-31
    Drug · Prescription · Approval202401355
  • MFDS drugLinaroutine Duo Tablet 2.5/850mg2024-04-30
    Drug · Prescription · Approval202401058
  • MFDS drugLinaroutine Duo Tablet 2.5/500mg2024-04-30
    Drug · Prescription · Approval202401059
  • MFDS drugLinaroutine Duo Tablet 2.5/1000mg2024-04-30
    Drug · Prescription · Approval202401060
  • MFDS drugLinaroutine Tablet 5mg2024-03-29
    Drug · Prescription · Approval202400697
  • MFDS drugLINARUTIN XR TABLET 5/1000MG2024-03-22
    Drug · Prescription · Approval202400628
  • MFDS drugLINARUTIN XR TABLET 2.5/1000MG2024-03-22
    Drug · Prescription · Approval202400629
  • MFDS drugShinpoong Acetaminophen Injection2024-02-22
    Drug · Prescription · Approval202400384
  • MFDS drugEmparoutine duo tablet 12.5/500mg2023-08-30
    Drug · Prescription · Approval202302563
  • MFDS drugEmparoutine duo tablet 12.5/850mg2023-08-30
    Drug · Prescription · Approval202302564
  • MFDS drugEmparoutine duo tablet 12.5/1000mg2023-08-30
    Drug · Prescription · Approval202302565
  • MFDS drugRoxagen XR Tab.2023-08-28
    Drug · Prescription · Approval202302536
  • MFDS drugElixia Tab. 60mg2023-04-25
    Drug · Prescription · Approval202301340
  • MFDS drugElixia Tab. 30mg2023-04-25
    Drug · Prescription · Approval202301341
  • MFDS drugCHOLOSTAR Tab. 2.5mg2023-03-31
    Drug · Prescription · Approval202301094
  • MFDS drugShinpoong sitaplus tab. 50/850mg2023-03-13
    Drug · Prescription · Approval202300857
  • MFDS drugShinpoong sitaplus tab. 50/500mg2023-03-13
    Drug · Prescription · Approval202300858
  • MFDS drugShinpoong sitaplus tab. 50/1000mg2023-03-13
    Drug · Prescription · Approval202300859
  • MFDS drugEzerosu Tab. 10/2.5mg2023-03-10
    Drug · Prescription · Approval202300829
  • MFDS drugSitaroutine Duo XR tab. 50/500mg2023-02-17
    Drug · Prescription · Approval202300590
  • MFDS drugSitaroutine Duo XR tab. 50/1000mg2023-02-17
    Drug · Prescription · Approval202300591
  • MFDS drugSitaroutine Duo XR tab. 50/1000mg2023-02-17
    Drug · Prescription · Approval202300592
  • MFDS drugDaparoutine Duo XR Tablet 10/1000mg2023-01-27
    Drug · Prescription · Approval202300355
  • MFDS drugFimadipine Tab. 30/2.5mg2022-12-27
    Drug · Prescription · Approval202204661
  • MFDS drugFimadipine Tab. 60/2.5mg2022-12-27
    Drug · Prescription · Approval202204662
  • MFDS drugBef XR tablet2022-12-21
    Drug · Prescription · Approval202204553
  • MFDS drugBaropera injection2022-08-04
    Drug · Prescription · Approval202203227
  • MFDS drugTerigglemet XR Tab. 20/1000mg2022-07-01
    Drug · Prescription · Approval202202740
  • MFDS drugTerigglemet XR Tab. 10/750mg2022-07-01
    Drug · Prescription · Approval202202741
  • MFDS drugTerigglemet XR Tab. 10/500mg2022-06-28
    Drug · Prescription · Approval202202675
  • MFDS drugTeriggle Tab. 20mg2022-04-27
    Drug · Prescription · Approval202201759
  • MFDS drugEmparoutine duo tablet 5/500mg2022-04-04
    Drug · Prescription · Approval202201360
  • MFDS drugEmparoutine duo tablet 5/1000mg2022-04-04
    Drug · Prescription · Approval202201361
  • MFDS drugEmparoutine duo tablet 5/850mg2022-04-04
    Drug · Prescription · Approval202201362
  • MFDS drugLovedion Injection2022-03-11
    Drug · Prescription · Approval202201006
  • MFDS drugDaparoutine 10mg Tablet2022-03-11
    Drug · Prescription · Approval202201016
  • MFDS drugDaparoutine 5mg TabletRevoked2022-03-08
    Drug · Prescription · Approval202200980
  • MFDS drugShinpoong Linagliptin Tab. 5mgRevoked2022-02-07
    Drug · Prescription · Approval202200559
  • MFDS drugGavely tablet2022-01-19
    Drug · Prescription · Approval202200347
  • MFDS drugDaparoutine Star Tablet 10/100mg2022-01-04
    Drug · Prescription · Approval202200044
  • MFDS drugGavelimet Tablet2021-10-25
    Drug · Prescription · Approval202107111
  • MFDS drugSitaroutine Tab. 50mg2021-03-22
    Drug · Prescription · Approval202102483
  • MFDS drugSitaroutine Tab. 25mg2021-03-22
    Drug · Prescription · Approval202102484
  • MFDS drugSitaroutine Tab. 100mg2021-03-22
    Drug · Prescription · Approval202102485
  • MFDS drugEmparoutine tablet 25mgRevoked2021-03-05
    Drug · Prescription · Approval202102111
  • MFDS drugEmparoutine tablet 10mgRevoked2021-03-05
    Drug · Prescription · Approval202102112
  • MFDS drugGastak SR Tab. 15mg2020-04-28
    Drug · Prescription · Approval202003104
  • MFDS drugDenausea EC tablet2020-04-03
    Drug · Prescription · Notification202002354
  • MFDS drugDybis Tab.2020-03-27
    Drug · Prescription · Approval202002163
  • MFDS drugRobavin Cap. (for export)2020-03-11
    Drug · Prescription · Approval202001691
  • MFDS drugDaibis XR Tab. 500mg2020-01-06
    Drug · Prescription · Approval202000084
  • MFDS drugPonstel Cap.2019-12-02
    Drug · Prescription · Notification201908188
  • MFDS drugFamcrin Tab. 250mg2019-10-28
    Drug · Prescription · Approval201907499
  • MFDS drugSseuk Join Tab.2019-08-07
    Drug · Prescription · Notification201905574
  • MFDS drugLostal XR Cap. 200mg2019-05-31
    Drug · Prescription · Approval201903645
  • MFDS drugLostal XR Cap. 100mg2019-05-31
    Drug · Prescription · Approval201903646
  • MFDS drugShinpoong Flu Suspension Powder 6mg/mL(50mL)Revoked2019-05-22
    Drug · Prescription · Approval201903330
  • MFDS drugAlz-Choline Syrup2019-03-29
    Drug · Prescription · Approval201901947
  • MFDS drugHyal Oneshot Inj.2019-03-08
    Drug · Prescription · Approval201901450
  • MFDS drugUtaren 2X Tab.2019-01-22
    Drug · Prescription · Approval201900320
  • MFDS drugTicarinta Tab. 90mgRevoked2018-11-27
    Drug · Prescription · Approval201804674
  • MFDS drugLosanne Tab.2018-10-31
    Drug · Prescription · Approval201804326
  • MFDS drugTostapin Tab. 5/10mgRevoked2018-10-30
    Drug · Prescription · Approval201804289
  • MFDS drugBAZECALD Tab.2018-10-10
    Drug · Prescription · Approval201803969
  • MFDS drugBef Tab.2018-03-28
    Drug · Prescription · Approval201801369
  • MFDS drugAlz-Choline Tab.2018-03-27
    Drug · Prescription · Approval201801335
  • MFDS drugCompacteno Tab.2017-11-29
    Drug · Prescription · Approval201708125
  • MFDS drugHayaron Inj. 1200mg2017-11-01
    Drug · Prescription · Notification201707678

Showing the 80 most recent of 344 records.

Clinical trials

data.go.kr

76 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 49 · Phase 1 11 · Phase 3 6 · Phase 2 6 · Phase 2a 2)

  • Bioequivalence아보탐스캡슐2026-04-08

    2 trial sites

  • Bioequivalence아보탐스캡슐2026-04-08

    2 trial sites

  • Bioequivalence보노판정20밀리그램2026-03-06

    2 trial sites

  • Bioequivalence로베타존정0.5밀리그램(로베글리타존황산염)2025-08-04

    2 trial sites

  • Bioequivalence브레트라정(레트로졸)2025-06-30

    2 trial sites

  • Phase 3SP-8203 주2024-10-14

    32 trial sites

  • Phase 2SPC10012024-08-01

    18 trial sites

  • Bioequivalence크라목신네오건조시럽2024-06-04

    2 trial sites

  • Bioequivalence크라목신듀오건조시럽2024-06-04

    2 trial sites

  • Bioequivalence스타페노캡슐2023-11-01

    2 trial sites

  • Bioequivalence브레트라정(레트로졸)2023-05-03

    2 trial sites

  • Phase 3SP5M002주2023-04-06

    32 trial sites

Show 64 more
  • Bioequivalence록스펜씨알정(록소프로펜나트륨)2022-12-08

    2 trial sites

  • Bioequivalence록스펜씨알정(록소프로펜나트륨)2022-12-06

    2 trial sites

  • Bioequivalence록스펜씨알정(록소프로펜나트륨)2022-09-20

    2 trial sites

  • Phase 2SPC10012022-07-18

    18 trial sites

  • Phase 2피라맥스정2022-06-13

    1 trial site

  • Bioequivalence뉴페리손정(에페리손염산염)2022-02-25

    2 trial sites

  • Bioequivalence몬테나정10밀리그램(몬테루카스트나트륨)2022-02-21

    2 trial sites

  • Bioequivalence에제로수정10/20밀리그램2021-11-24

    1 trial site

  • Phase 2SPC10012021-10-13

    19 trial sites

  • Phase 3피라맥스정2021-08-27

    33 trial sites

  • Phase 1/2SP5M002주2021-06-09

    2 trial sites

  • Phase 3SP5M001주2021-03-16

    14 trial sites

  • Bioequivalence알츠코린정2020-06-08

    2 trial sites

  • Phase 2피라맥스정2020-05-13

    13 trial sites

  • Phase 1SPC2001, SPC50012019-12-30

    2 trial sites

  • Bioequivalence베타미론서방정50밀리그램(미라베그론)2019-07-11

    2 trial sites

  • Bioequivalence베타미론서방정50밀리그램(미라베그론)2019-07-11

    2 trial sites

  • Phase 2bSP-8203 주2018-12-05

    14 trial sites

  • Bioequivalence베타미론서방정50밀리그램(미라베그론)2018-07-10

    2 trial sites

  • Bioequivalencedienogest2016-09-12

    2 trial sites

  • Bioequivalence비리테노정2016-09-09

    2 trial sites

  • Bioequivalence티카린타정90밀리그램2016-08-02

    2 trial sites

  • Bioequivalence알츠코린정(콜린알포세레이트)2016-06-30

    2 trial sites

  • Phase 2aSP-8203 주2015-09-22

    8 trial sites

  • Phase 1SP5M001주2015-05-14

    2 trial sites

  • Bioequivalence칸세틸플러스정2015-04-15

    2 trial sites

  • Bioequivalence칸세틸정16밀리그램(칸데사르탄실렉세틸)2015-03-18

    2 trial sites

  • Phase 3(가칭) 칸데암로정2015-02-13

    11 trial sites

  • Phase 1(가칭)에제로수정2015-01-09

    1 trial site

  • Phase 1(가칭) 칸데암로정2014-12-31

    1 trial site

  • Bioequivalence실로패스캡슐 4밀리그램(실로도신)2014-12-24

    2 trial sites

  • Phase 1SP3R0012014-12-12

    1 trial site

  • Bioequivalence프레야지정60밀리그램(다폭세틴염산염)2014-11-26

    2 trial sites

  • Phase 2aSPP-501정2014-11-25

    1 trial site

  • Bioequivalence페노렌캡슐(미세화페노피브레이트구형과립)2014-11-21

    2 trial sites

  • Bioequivalence페트리센정80밀리그램(페북소스타트)2014-11-20

    2 trial sites

  • Bioequivalence베라졸정 20mg2014-10-02

    2 trial sites

  • Bioequivalence텔미디탄정80/5밀리그램2014-10-02

    2 trial sites

  • Bioequivalence이레피논정(게피티니브)2014-09-19

    2 trial sites

  • Phase 3(가칭)에제로수정2014-08-06

    20 trial sites

  • Bioequivalence잘프로정(잘토프로펜)2014-07-25

    2 trial sites

  • Phase 2(가칭) 칸데암로정2014-05-07

    22 trial sites

  • Bioequivalence바로타다정20밀리그램(타다라필)2014-03-25

    2 trial sites

  • Bioequivalence아모디탄정 5/40밀리그램2013-11-08

    1 trial site

  • Bioequivalence듈로타캡슐60밀리그램(둘록세틴염산염)2013-10-10

    2 trial sites

  • Bioequivalence바로페질정10밀리그램(도네페질염산염일수화물)2013-09-30

    2 trial sites

  • Phase 1SP-8203 주2013-09-25

    1 trial site

  • Bioequivalence바로콕스캡슐200밀리그램(세레콕시브)2013-06-13

    2 trial sites

  • Bioequivalence시타글루정100mg(시타글립틴인산염수화물)2013-06-05

    1 trial site

  • Phase 1(가칭) 칸데암로정2013-05-24

    1 trial site

  • Bioequivalence신풍비페닐디메틸디카르복실산염/우르소데옥시콜산캡슐(가칭)2013-05-15

    2 trial sites

  • Bioequivalence잘프로정(잘토프로펜)2013-04-15

    2 trial sites

  • Phase 1피라맥스과립2013-03-15

    1 trial site

  • Bioequivalence투스타핀정5/20밀리그램2013-02-22

    2 trial sites

  • Bioequivalence아덱셀런스패취10(리바스티그민)2013-02-01

    2 trial sites

  • Bioequivalence하이듀오정2013-01-29

    1 trial site

  • Bioequivalence암로발탄정10/160밀리그램2012-10-10

    1 trial site

  • Bioequivalence바로필정100밀리그램(실데나필시트르산염)2012-08-28

    1 trial site

  • Bioequivalence브레트라정(레트로졸)2012-08-01
  • Bioequivalence솔페나신정10밀리그램(숙신산솔리페나신)2012-07-19

    1 trial site

  • Phase 1블루벡필름코팅정400밀리그램(이매티닙메실산염)2012-07-13

    1 trial site

  • Bioequivalence큐프론정(염산시프로플록사신)(수출명 : SP Ciprofloxacin Tablets, SHINPOONG QUPRON Tablets, SHINPOONG QUPRON Film coated tablet)2012-06-22

    2 trial sites

  • Phase 1멧퓨어엑스엘정(에스메토프로롤숙시네이트)2012-01-18

    1 trial site

  • Phase 1멧퓨어엑스엘정(에스메토프로롤숙시네이트)2012-01-13

    1 trial site

Key disclosures

KRX KIND via OpenDART
Show 3 more events

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 54 more patents

AI reads

MAA server logs · IP-verified
83
Times AI engines pulled SHINPOONG PHARMACEUTICAL CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

80
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 2
Last 7 days
60
live 2
Last 30 days
83
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot74
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SHINPOONG PHARMACEUTICAL CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

L&C BIO Co., Ltd1 shared

L&C BIO manufactures human tissue grafts across 11 tissue types, including the acellular dermal matrix MegaDerm, plus tissue-based medical devices.

BioPlus Co., Ltd1 shared

Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.

SHINHUNG CO.,LTD1 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

BASKHANBIOPharma Inc.1 shared

Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.

AHN-GOOK PHARMACEUTICAL Co., Ltd.1 shared

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

OSANG HEALTHCARE CO.,LTD.1 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

i-SENS, Inc.1 shared

Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.

WSI Co., Ltd.1 shared

Founded and KOSDAQ-listed in 2018, WSI distributes spine/joint devices and has expanded into medical robots and pharma via subsidiaries.

GC Medical Science Corporation1 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

PharmaResearch Co., Ltd.1 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

SD BIOSENSOR INC.1 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition